• Increase font size
  • Default font size
  • Decrease font size
home | about us | contact us
Search
Search Only:

Search Keyword exact sciences

Total: 50 results found.

...  ETEX Corporation Exactech  ...
... Smoking Despite decades of public health and medical intervention, smoking remains one of the most preventable causes of death in the United States1.Smoking continues to exact a staggering toll on human ...
3. Bullish and Bearish Signals in Healthcare
(Premium Content/Subscriber Only Content)
... called 2,4,6-tribromoanisole (TBA) in bottles containing the 500mg formulation of Glumetza. See their chart here. Exact Sciences Corporation (NasdaqCM: EXAS) Exact Sciences Corporation, a molecular diagnostics ...
...  "It has been my honor to lead this great organization during the last decade of extraordinary growth in the 113-year history of Scott & White. Dr. Pryor is exactly the right ...
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS) today announced that it has filed with the Securities and Exchange Commission a universal shelf registration statement on Form-3 providing ...
... multi-route NexACT® drug delivery technology and int rnal pipeline through out-licensing arrangements and partnerships, announced today that management will hold a conference call to discuss 2010 second ...
... acute spinal cord injuries. Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced its schedule ...
... in many ways," explains Dr. Tenopir. "Although the exact monetary amount of the returns in grants varies with the mission of the institution, our research shows that the collections and services of all ...
... exactly these challenges.” About RR Donnelley RR Donnelley (NASDAQ:RRD) is a global provider of integrated communications. Founded more than 145 years ago, the company works collaboratively ...
... stating that if the trial was run exactly as designated, and the results were positive, then the company's drug would be approved. That is a significant ace in the hole for AVNR. During their recent ...
... host a conference call to discuss second quarter 2010 operating and financial results on Friday, August, 6, 2010 at 9:00 a.m. Eastern time. Exact Sciences Corp. (Nasdaq: EXAS) today announced that it ...
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS) today announced that it will present at the Canaccord Genuity 30th Annual Global Growth Conference, which is being held Aug. 1012, ...
... reconciliation of this forward-looking non-GAAP financial measure due to the difficulty in forecasting and quantifying the exact amount of the items excluded from the non-GAAP financial measure that will ...
... Corporation's entrepreneurship and dedication to developing industry-leading and internationally-recognized products is exactly the kind of drive we look for when partnering with innovative Canadian firms." ...
... cancer-related death." Exact Sciences Corp. (Nasdaq: EXAS) today announced that data being presented this afternoon at the annual meeting of the American Association of Clinical Chemistry (AACC) demonstrates ...
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS) today announced its financial results for the second quarter ended June 30, 2010. “We remained focused on our keyriorities during ...
... both of these arms of immunity are needed for successful treatment of genital herpes." Shares of Antigenics jumped more than 15% on the news, closing the day at 91 cents. Exact Sciences Corp (Nasdaq: ...
MADISON, Wis. & LIEGE, Belgium--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS) and OncoMethylome Sciences S.A. (Brussels: ONCOB) today announced that they have entered into a license agreeent ...
... October 29-31 is now available. NexMed, Inc. (Nasdaq: NEXM), backed by a revenue generating CRO business and seeking to leverage its proprietary, multi-route NexACT drug delivery technology and internal ...
... during his 32-year career with Hoffmann-LaRoche.  Currently, Mr. Zenner is Chairman of the Board of ArQule, Inc. and Exact Sciences Corporation and a director of West Pharmaceutical Services.  He ...
... July 28, 2010, to discuss its financial results and company progress for the second quarter ended June 30, 2010 Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company will host a conference ...
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company will host a conference call and question-and-answer session on July 28, 2010, at 10 a.m. EDT,o discuss ...
... that these iron-containing MWCNT particles could destroy the tumors when hit with a laser. "To find the exact location of the nanoparticle ...
24. RxNews Recap for Friday 07.16.10
(Home Page/Home Page)
... (Nasdaq and OMX Nordic Exchange: EPCT) has amended the exercise price of its Series A Warrants and Series B Warrant sold in June 2010 from $1.57 per share to $1.64 per share.  Exact Sciences ...
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq:EXAS), a company focused on the early detection and prevention of colon cancer, is pleased to welcome Daniel J. Levangie, Lionel N. Strling ...
...  “In a scientific setting, it is important to know exactly what you are studying and what you are providing to subjects/patients. USANA Health Sciences provides remarkable scientific and research support, ...
... Inc. (NASDAQ: DSCI), a medical device and pharmaceutical company focused on advanced wound care, announces the achievement of regulatory and commercial milestones. Exact Sciences Corp. (Nasdaq: EXAS) ...
  MADISON, Wis.--Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company’s annual meeting of stockholders will be webcast live on Friday, July 16, at 11 a.m. EDT.   The webcast will ...
... validate their data.  DNA sequencing – the process of determining the exact order of the billions of chemical building blocks that make up DNA – is a massive computational challenge that requires an extremely ...
... protection to September 2021 and is one in a series of patents and pending applications that NexMed owns on Vitaros® and the underlying NexACT technology. Oculus Innovative Sciences, Inc. (NASDAQ:OCLS), ...
... of preferred stock convertible into common shares of Neoprobe Corporation. NexMed, Inc. (Nasdaq: NEXMD), a specialty CRO with a pipeline of products based on the NexACT® technology, today announced that ...
... longer infusion times and higher drug doses. "We are excited to have launched the clinical development of this drug with the objective of defining the exact dosing schedule to take into a Phase II trial ...
... June 23, 2010. Exact Sciences Corp. (Nasdaq: EXAS) today announced that it will present at the Fifth Annual Piper Jaffray Europe Conference, which is being held June 22-23, 2010, at the Andaz Liverpool ...
MADISON, Wis.--Exact Sciences Corp. (Nasdaq: EXAS) today announced that it will present at the Fifth Annual Piper Jaffray Europe Conference, which is being held June 22-23, 2010, at the Andaz Liverpool ...
... an experienced management team committed to improving lives is exactly why BioGenerator was formed. We are also excited to be partnering with other investors from the region in this and other recent ...
... cruciale pour permettre aux sponsors de recherches de gérer avec exactitude les budgets des subventions. Toutefois, les coûts réels ne représentent qu'un aspect de la question : certains protocoles ...
ANN ARBOR, Mich. -- Exactly one year after purchasing a 174-acre research campus formerly used for advanced pharmaceutical development, the University of Michigan has selected the leader who will steer ...
... Exact Cost, Facet Solutions, Flexible Stenting Solutions, Health Integrated, HiLin Life Products, Insite Medical, LL Tech, Lucid, MacuCLEAR Inc., MedicaSafe, Morris Innovative Research, Myconostica, Nanobiotix, ...
... Accelerating Lead Optimization:  In vivo Fast PK Studies Using the Exactive™ Orbitrap™, Rohan A. Thakur, Ph.D., Associate Director, Specialized Mass Spectrometry, Taylor Technology, a PharmaNet Company ...
... technically advanced collagen products for medical device production for more than 20 years.  The company sources bovine collagen from Australia and processes it to exacting standards and customer ...
...  suppressed by polymerized actin. The cytoskeletal mechanisms that promote reattachment of CTCs match exactly with the mechanisms supporting tubulin microtentacles (McTN), which the researchers have ...
...  About Immunome Immunome is a discovery stage biopharmaceutical company that has created a proprietary Native Human Monoclonal Antibody (N-huMAB) platform. N-huMAbs are in the exact structures created ...
... Haina Pharmaceutical, Inc. have been recognized as Heilongjiang's Model Companies by the Heilongjiang Provincial Government. Exact Sciences Corp. (Nasdaq: EXAS) today announced that it will present at ...
MADISON, Wis.--Exact Sciences Corp. (Nasdaq: EXAS) today announced that it will present at the Jeffries 2010 Global Life Sciences Conference, which is being held June 8-11, at the Grand Hyatt in New ...
... The condition may cause infertility and currently has no cure. "The Daisy PETAL study was successful, all primary and secondary efficacy endpoints were met, and provided exactly the information we need ...
...  Exact Causes of ALS Still Unknown II-6 Major Milestones in ALS Treatment Arena II-6 ...
...  Waters Xevo G2 QTof Mass Spectrometer Xevo G2 QTof is a next-generation benchtop exact mass MS/MS mass spectrometer and ...
...  “The Daisy PETAL study was successful, all primary and secondary efficacy endpoints were met, and provided exactly the information ...
... Investigational New Drug application number for its NexACT-based alprostadil treatment for Raynaud’s syndrome, ahead of a pre-IND meeting in mid-July 2010 to discuss its proposed Phase 2/3 protocol. The ...
... data will also help you set exact fee schedules for speaking engagements.Boost attendance: Our attendance benchmarks, across different program types, will help you plan more effective programs.Create engaging ...

Get Free Email and Phone News Alerts

* Your email address:
* Preferred Format:
* Enter the security code shown:
 
Home | Privacy Policy
© 2010 BioMedReports.com. All rights reserved